Similar articles

• Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment.

  Shea KL, Gavin KM, Melanson EL, Gibbons E, Stavros A, Wolfe P, Kittelson JM, Vondracek SF, Schwartz RS, Wierman ME, Kohrt WM. Shea KL, et al. Menopause. 2015 Oct;22(10):1045-52. doi: 10.1097/GME.0000000000000430. Menopause. 2015. PMID: 25783468 Free PMC article. Clinical Trial.
• Body composition and circulating estradiol are the main bone density predictors in healthy young and middle-aged men.

  Bilha SC, Branisteanu D, Buzduga C, Constantinescu D, Cianga P, Anisie E, Covic A, Ungureanu MC. Bilha SC, et al. J Endocrinol Invest. 2018 Aug;41(8):995-1003. doi: 10.1007/s40618-018-0826-z. Epub 2018 Jan 16. J Endocrinol Invest. 2018. PMID: 29336002
• Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis.

  Takeuchi I, Kobayashi S, Hida Y, Makino K. Takeuchi I, et al. Colloids Surf B Biointerfaces. 2017 Jul 1;155:35-40. doi: 10.1016/j.colsurfb.2017.03.047. Epub 2017 Mar 24. Colloids Surf B Biointerfaces. 2017. PMID: 28391082
• Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist.

  Mueller A, Zollver H, Kronawitter D, Oppelt PG, Claassen T, Hoffmann I, Beckmann MW, Dittrich R. Mueller A, et al. Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):95-100. doi: 10.1055/s-0030-1255074. Epub 2010 Jul 12. Exp Clin Endocrinol Diabetes. 2011. PMID: 20625973 Clinical Trial.
• Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial.

  Cleemann L, Holm K, Kobbernagel H, Kristensen B, Skouby SO, Jensen AK, Gravholt CH. Cleemann L, et al. Eur J Endocrinol. 2017 Feb;176(2):233-242. doi: 10.1530/EJE-16-0582. Epub 2016 Nov 23. Eur J Endocrinol. 2017. PMID: 27881458 Clinical Trial.